Creo Medical Group PLC (AIM:CREO)
London · Delayed Price · Currency is GBP · Price in GBX 12.75
-0.16 (-1.20%)
Sep 9, 2025, 4:15 PM GMT+1
Creo Medical Group Market Cap
Creo Medical Group has a market cap or net worth of 51.92 million as of September 9, 2025. Its market cap has decreased by -49.97% in one year.
Market Cap
51.92M
Enterprise Value
47.62M
Revenue
4.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.75
Market Cap Chart
Since December 9, 2016, Creo Medical Group's market cap has decreased from 64.46M to 51.92M, a decrease of -19.45%. That is a compound annual growth rate of -2.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 51.92M | -33.79% |
| Dec 31, 2024 | 78.42M | -51.05% |
| Dec 29, 2023 | 160.20M | 255.34% |
| Dec 30, 2022 | 45.08M | -83.01% |
| Dec 31, 2021 | 265.37M | -13.37% |
| Dec 31, 2020 | 306.31M | 12.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 185.62B |
| GSK plc | 58.98B |
| Haleon | 32.14B |
| Smith & Nephew | 12.27B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 3.76B |
| HUTCHMED (China) | 1.98B |
| Genus | 1.76B |